Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 171

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 171
---
. Aadi’s board of directors reached the unanimous conclusion to approve the PIPE Financing in light of the various factors described above and other factors that each member of Aadi’s board of directors felt were appropriate. In view of the wide variety of factors considered by Aadi’s board of directors in connection with its evaluation of the PIPE Financing and the complexity of these matters, Aadi’s board of directors did not consider it practical, and did not attempt to quantify, rank or otherwise assign relative weights to the specific factors it considered in reaching its decision and did not undertake to make any specific determination as to whether any particular factor, or any aspect of any particular factor, was favorable or unfavorable to the ultimate determination of Aadi’s board of directors. Rather, the recommendation of Aadi’s board of directors was based on the totality of information presented to it and the investigation conducted by it. In considering the factors discussed above, individual directors may have given different weights to different factors. PIPE Financing and Subscription Agreement On December 19, 2024, Aadi entered into the Subscription Agreement with each of the PIPE Investors, pursuant to which Aadi agreed to sell to the PIPE Investors (i) 21,592,000 shares of Aadi’s common stock, par value $0.0001 per share, at a purchase price of $2.40 per share, and (ii) 20,076,500 Pre-Funded Warrants toacquire shares of Aadi’s common stock, at a purchase price of $2.3999 per share, for an aggregate purchase price of $100 million. The Pre-Funded Warrantswill have an exercise price of $0.0001 per share of common stock, be immediately exercisable, and remain exercisable until exercised in full. The holders of Pre-Funded Warrantsmay not exercise a Pre-Funded Warrantif the holder, together with its affiliates, would beneficially own more than 4.99% or 9.99%, at the election of the holder, of the number of shares of Aadi’s common stock outstanding immediately after giving effect to such exercise. The holders of Pre-FundedWarrants may increase or decrease such percentages not in excess of 19.99% by providing at least 61 days’ prior notice to the Company. The closing of the PIPE Financing is expected to occur on a date that is no later than five business days from the date on which the Required Stockholder Approval (as defined in the Subscription Agreement) is obtained. Jefferies